MTEX MANNATECH INC

Nasdaq Medicinal Chemicals & Botanical Products TX CIK: 0001056358
AI RATING
STRONG_SELL
88% Confidence

Investment Thesis

MTEX faces critical financial distress with negative stockholders equity of -$5.6M, indicating technical insolvency on a book basis. Declining revenue (-8.3% YoY) combined with negative operating margins and severely constrained liquidity create an unsustainable financial position. While positive free cash flow provides near-term survival capability, without significant operational turnaround, bankruptcy risk is substantial.

Strengths

  • + High gross margin of 75.7% indicates strong pricing power and product demand at gross level
  • + Positive free cash flow of $997K despite negative operating income demonstrates some operational cash generation capability
  • + Cash reserves of $7.0M provide short-term liquidity cushion

Risks

  • ! Negative stockholders equity of -$5.6M indicates technical insolvency with liabilities exceeding assets
  • ! Revenue declining 8.3% YoY combined with negative operating margin signals deteriorating business fundamentals
  • ! Severely constrained liquidity with current ratio 1.09x and quick ratio 0.59x creates minimal financial flexibility
  • ! Zero insider transactions in past 90 days suggests lack of management confidence in company prospects

Key Metrics to Watch

Financial Metrics

Revenue
24.9M
Net Income
950.0K
EPS (Diluted)
$0.49
Free Cash Flow
997.0K
Total Assets
29.9M
Cash
7.0M

Profitability Ratios

Gross Margin 75.7%
Operating Margin -0.7%
Net Margin 3.8%
ROE N/A
ROA 3.2%
FCF Margin 4.0%

Balance Sheet & Liquidity

Current Ratio
1.09x
Quick Ratio
0.59x
Debt/Equity
N/A
Debt/Assets
118.6%
Interest Coverage
N/A
Long-term Debt
2.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-15T08:16:41.440159 | Data as of: 2026-03-31 | Powered by Claude AI